DBV TECHNOLOGIES (EPA:DBV)

BRIEF

published on 01/20/2026 at 11:41, 9 days 11 hours ago

Thresholds crossed at DBV Technologies by JP Morgan Chase & Co.

Shares And Voting Rights DBV Technologies Financial Contracts JP Morgan Participation Thresholds
BRIEF

published on 01/20/2026 at 09:20, 9 days 13 hours ago

DBV Technologies: Thresholds crossed by Bpifrance

Investment Crossing Thresholds Shares And Voting Rights Bpifrance DBV Technologies
BRIEF

published on 01/20/2026 at 09:17, 9 days 13 hours ago

Threshold crossings at DBV Technologies

Crossing Thresholds Shares And Voting Rights DBV Technologies Caisse Des Dépôts Bpifrance Participations
BRIEF

published on 01/17/2026 at 00:16, 12 days 22 hours ago

DBV Technologies generates €166.7 million through the exercise of Warrants

Funding DBV Technologies Food Allergies Viaskin® Peanut Subscription Vouchers
BRIEF

published on 01/12/2026 at 22:05, 17 days ago

DBV Technologies: Status of voting rights and shares as of December 31, 2025

Share Capital Voting Rights Actions NYSE Euronext DBV Technologies
BRIEF

published on 01/12/2026 at 22:05, 17 days ago

DBV Technologies Updates Voting Rights and Shares as of December 31, 2025

Voting Rights DBV Technologies NYSE Euronext Paris Shares Update December 2025
PRESS RELEASE

published on 01/12/2026 at 22:00, 17 days 1 hour ago

Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025
Press release on total number of voting rights and shares of the Company as of December 31, 2025, in compliance with Article 223-16 of AMF General Regulations

Voting Rights Shares AMF Regulations NYSE Euronext Paris December 31 2025
BRIEF

published on 12/16/2025 at 22:10, 1 month 13 days ago

DBV Technologies: Encouraging Results from the VITESSE Study on the Peanut Allergy Patch

DBV Technologies Clinical Results Viaskin Peanut Peanut Allergy SPEED Study
BRIEF

published on 12/16/2025 at 22:10, 1 month 13 days ago

DBV Technologies Reports Positive Phase 3 Results for VIASKIN Peanut Patch

Phase 3 Trial Child Health Viaskin Peanut Peanut Allergy BLA Submission
PRESS RELEASE

published on 12/16/2025 at 22:05, 1 month 13 days ago

DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
DBV Technologies reports positive Phase 3 VITESSE Trial results for VIASKIN Peanut Patch in children aged 4-7 years, meeting primary endpoint with notable treatment response rates and safety profile

Phase 3 DBV Technologies Peanut Allergy Viaskin Peanut Patch VITESSE Trial

Published on 01/29/2026 at 18:45, 4 hours 19 minutes ago

Silver Spruce Appoints Vice-President of Exploration
Published on 01/29/2026 at 18:00, 5 hours 4 minutes ago

PPX Mining Announces Grant of Restricted Share Units and Deferred Share Units
Published on 01/29/2026 at 17:00, 6 hours 4 minutes ago

Sparta Reports on Delay in Filing Annual Financial Statements
Published on 01/29/2026 at 14:30, 8 hours 34 minutes ago

Innodata Selected by Palantir to Accelerate Advanced Initiatives in AI-Powered Rodeo Modernization
Published on 01/29/2026 at 14:00, 9 hours 4 minutes ago

Horizon Aircraft Partners with RAMPF to Manufacture the Fuselage for its Aircraft

View all ACCESSWIRE

Published on 01/29/2026 at 21:02, 2 hours 1 minute ago

Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc
Published on 01/29/2026 at 21:01, 2 hours 3 minutes ago

Form 8.3 - The Vanguard Group, Inc.: JTC plc
Published on 01/29/2026 at 20:59, 2 hours 4 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited
Published on 01/29/2026 at 20:57, 2 hours 6 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 01/29/2026 at 20:57, 2 hours 6 minutes ago

2CRSi SA: Record first half: >€198m

View all EQS

Published on 01/29/2026 at 18:00, 5 hours 4 minutes ago

GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 5 hours 19 minutes ago

LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 5 hours 19 minutes ago

Cegedim generated LFL revenue growth of 1.1% in 2025
Published on 01/29/2026 at 17:40, 5 hours 24 minutes ago

ALTEN: Annual revenue 2025
Published on 01/29/2026 at 10:07, 12 hours 56 minutes ago

Deezer confirms demonetization of up to 85% of AI-music streams due to fraud and moves to sell AI-detection tech

View all LES ECHOS COMFI WIRE

News